Interventional Oncology, a bi-monthly publication, is an addition to San Lucas Medical’s strong collection of journals, which includes complementary titles in the field of oncology and gastronenterology. The new journal will benefit from San Lucas Medical’s strong multimedia publishing platform.

“San Lucas Medical’s global reach and its emphasis on scientific rigour complement the mission of the IOS,” said Dr Jaak Ph. Janssens, Chair of the IOS, who will be the new publication’s editor-in-chief. “Interventional Oncology" will lead the way forward in interventional oncology, with groundbreaking research shared amongst industry, researchers and clinicians.”

The new partnership with San Lucas Medical will ensure that advances in imaging and image guidance for the detection, characterization, targeting and cancer therapy will be shared amongst clinicians, researchers and industry through peer-reviewed articles, editorials, case reports and industry/technology reviews.

Founded in Belgium in 2008, the Interventional Oncology Society is an international hub for world experts in the field of interventional oncology. It was created by professionals to focus on the issue of medical devices used in the diagnosis and treatment of patients with a high risk of malignancy, and cancer patients, stimulating the rapid diffusion of new and proven technologies and their eventual used in clinical practice.

Nahida Zaman, CEO of San Lucas Medical said: “The IOS is an internationally renowned society working at the cutting edge of clinical and industry research and rightly requires its publishing partners to deliver world class products, making full use of advanced authoring and dissemination tools. The fact that San Lucas Medical has been chosen to fulfil this requirement demonstrates our considerable knowledge and experience of medical publishing.”

San Lucas Medical director Seun Moses Abimbola added: “The Journal of Interventional Oncology is not only a forum for research breakthroughs. It will help disseminate the science that can alter the fate of cancer patients. The need for this new journal is very clear, and the time for it is right.”

Notes for Editors
The Interventional Oncology Society (IOS) has been created by professionals for professionals to focus scientifically on the issue of medical devices that are used in the diagnosis and treatment of patients with a high risk of malignancy, and cancer patients. Since the use of equipment and instruments has a far larger impact on patients’ outcome and wellbeing, it is of paramount importance that the IOS develops methods to evaluate correctly the indications, efficacy and safety of medical devices. In addition, the IOS will support the rapid diffusion of new technology and how it should be used correctly. For this, the IOS stimulates the organization of congresses and meetings, publishes a journal with multimedia extension, and creates an environment where clinicians, researchers and industry find a trustful home to communicate.
www.interventionaloncologysociety.org

San Lucas Medical is a specialist medical and academic publisher and educator. For thousands of physicians and pharmaceutical specialists across the globe San Lucas Medical provides critical news, analysis and access to information of unparalleled quality. Its journals cover some of the industry’s most cutting edge titles, including the European Journal of Clinical and Medical Oncology.
www.sanlucasmedical.com

For more information contact:
Nahida Zaman. CEO, San Lucas Medical
nahida.zaman@sanlucasmedical.com
+44 (0) 207 096 0728